Biotia provides hospital-acquired infection prevention powered by artificial intelligence and harnesses next-generation DNA sequencing to look at high-risk patients and prevent them from getting sick.
Company (Alive / Active)
100 Avenue of the Americas
New York, 10013
New York, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)